Latest News about CHRS
Recent news which mentions CHRS
From Benzinga
For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say
June 30, 2023
From MarketWatch
Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability
June 20, 2023
From Benzinga
From Benzinga
From Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
From Benzinga
Crude Oil Rises; Adobe Posts Upbeat Results
June 16, 2023
From Benzinga
From Benzinga
Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday
June 16, 2023
From Benzinga
US Stocks Mixed; Dow Gains 50 Points
June 16, 2023
From Benzinga
From Motley Fool
From Benzinga
AbbVie vs Coherus: Dispute Emerges over Upcoming Launch of Low-Cost Biosimilar, Yusimry
June 15, 2023
From Benzinga
Coherus' Toripalimab/Chemo Combo Cuts Death Risk By 37% In Nasopharyngeal Cancer Patients
June 06, 2023
Tickers
CHRS
From Benzinga
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed'
June 01, 2023
From Benzinga
Why Is AbbVie Stock Trading Down Today?
June 01, 2023
From Benzinga
Top 5 Health Care Stocks That Could Blast Off In May
May 26, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
May 19, 2023
From Benzinga
Vodafone, Calliditas Therapeutics, Rumble And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
May 16, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.